Clinical features
|
Age, median (IQR) |
63 (51–74) |
75 (63–84) |
<0.0001 |
Sex |
|
|
0.016 |
Female, n (%) |
39 (39%) |
104 (54.2%) |
|
Male, n (%) |
62 (61%) |
88 (45.8%) |
|
NIHSS score, median (IQR) |
13 (7–18) |
18 (13–22) |
<0.0001 |
Time to admission, median (IQR) |
107 (68–186) |
135 (68–302) |
0.107 |
Imaging features
|
Occlusion side |
|
|
0.017 |
Right, n (%) |
57 (56%) |
79 (41%) |
|
Left, n (%) |
44 (44%) |
113 (59%) |
|
Occlusion location |
|
|
0.280 |
ICA Terminus, n (%) |
25 (25%) |
55 (29%) |
|
M1, n (%) |
50 (49%) |
99 (51%) |
|
M2, n (%) |
25 (25%) |
34 (18%) |
|
M3, n (%) |
1 (1%) |
4 (2%) |
|
e-ASPECTS, median (IQR) |
9 (8–10) |
9 (7–10) |
0.002 |
Acute ischemic Volume (mL), median (IQR) |
9.14 (5–20) |
12.52 (5–28) |
0.047 |
Non-acute ischemic volume (mL), median (IQR) |
0.39 (0–0) |
0.50 (0–1) |
0.040 |
Local acute ischemic volume
|
M1 (mL), median (range) |
0.0 (0.0–9.5) |
0.0 (0.0–13.7) |
0.006 |
M2 (mL), median (range) |
0.3 (0.0–8.8) |
0.8 (0.0–18.8) |
0.005 |
M3 (mL), median (range) |
0.0 (0.0–12.5) |
0.4 (0.0–20.2) |
0.002 |
M4 (mL), median (range) |
0.0 (0.0–7.5) |
0.0 (0.0–11.7) |
0.004 |
M5 (mL), median (range) |
0.8 (0.0–17.9) |
1.3 (0.0–32.0) |
0.034 |
M6 (mL), median (range) |
0.1 (0.0–23.0) |
0.8 (0.0–25.3) |
0.012 |
Caudate (mL), median (range) |
0.0 (0.0–2.6) |
0.0 (0.0–2.6) |
0.540 |
Insula (mL), median (range) |
0.0 (0.0–8.0) |
4.7 (0.0–8.0) |
0.201 |
Internal capsule (mL), median (range) |
0.0 (0.0–4.7) |
0.0 (0.0–4.8) |
0.744 |
Lentiform (mL), median (range) |
2.3 (0.0–5.8) |
2.6 (0.0–5.8) |
0.679 |
Brain volume (L), mean (±SD) |
1.30 (±0.16) |
1.26 (±0.15) |
0.043 |
Cortical CSF volume (%), median (IQR) |
6.16 (4–9) |
8.7 (6–10) |
<0.0001 |
Lateral ventricle volume (%), median (IQR) |
2.4 (1–3) |
3.4 (2–5) |
<0.0001 |
Circulation deficit volume, median (IQR) |
15.8 (1–36) |
30.42 (6–54) |
0.001 |
CTA CS score, median (IQR) |
3.0 (2–3) |
2.0 (1–3) |
<0.001 |